To determine whether the increased size of CLL cells induced by CD40 stimulation was mediated by AKT, co-cultured CLL cells were again treated with the AKT inhibitor AZD5363. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.